Teva, Others Seek To Nix Retailers' Pay-For-Delay Suits
By Vin Gurrieri ( June 3, 2015, 3:37 PM EDT) -- Teva Pharmaceuticals USA Inc., Boehringer Ingelheim Pharmaceuticals Inc. and other pharmaceutical companies accused in multidistrict litigation of engaging in a pay-for-delay scheme over the stroke drug Aggrenox told a Connecticut federal court to toss complaints by six retailers because they didn't show they directly bought the drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.